Home
University & Research Institutions

Sector: University & Research Institutions

Stealthy biotech buys up patent portfolios in string of recent deals

Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months

Columbia University scores $185 million jury verdict on back of anti virus patents

NortonLifeLock has pledged to appeal the jury verdict, which could balloon to $550 million with enhanced damages for wilful infringement

CRISPR FTO complexities not going anywhere in wake of Broad Institute victory, says IP chief on the CVC side

Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech

Latest content

mRNA IP will be hot property beyond the pandemic

$3.2 billion Sanofi deal is unlikely to be the last as Big Pharma seeks to consolidate its position in the cutting-edge field

12 August 2021

Pharma should make good use of the UPC from the beginning, says Bayer’s head of IP

There are a lot of potential benefits to the new system, but we need to integrate it into our strategies to make sure it works, explains Joerg Thomaier

11 August 2021

Healthcare Royalty Partners’ $750 million IPO to be next milestone for a booming market

The company is hoping to raise cash to help expand its purchasing power when acquiring pharmaceuticals revenue streams

05 August 2021

Ofinno's Honda and Xiaomi deals point to strong 5G patent secondary market

The Virginia-based R&D outfit has made a string of sales to big names in consumer tech over recent months, with Samsung another prominent customer

26 July 2021

UK Supreme Court quashes £220 million third-party lawsuit against patent litigant

Country’s National Health Service fails to overturn rules on damages sought by healthcare providers affected by failed enforcement

07 July 2021

Everything you need to know about SCOTUS’ Minerva ruling on assignor estoppel

In a 5-4 decision the court’s justices significantly narrowed the scope of the doctrine that prevents assignors from challenging patents in court.

01 July 2021

University and Big Pharma JV’s $145 million take-off is a big boost for tech transfer dealmaking

Apollo Therapeutics is an innovative biotech formed by three UK universities and three major companies, with a promising model for creating and monetising life sciences IP

29 June 2021